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The effect of pregnancy on kidney function
in renal allograft recipients
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The effect of pregnancy on kidney function in renal allograft recipients.
In women with renal transplants glomerular filtration rate (GFR)
increases during pregnancy but how soon the increment occurs, its
relation to pre-pregnancy GFR, and the overall pattern of change are
unknown. Twenty-four hour creatinine clearances (24-hr Ccr) were
measured prospectively in ten pregnancies in eight allograft recipients
before conception, throughout pregnancy, 8 to 12 weeks postpartum,
and 4 to 6 monthly thereafter. Inulin (C1) and creatinine (Cr) clear-
ances during infusion were also determined and protein excretion was
evaluated. The results were compared to those in similar studies in ten
healthy women. By the tenth gestational week 24-hr Ccr was 124 (SD)
15.9 ml/min in healthy women (an increase of 38%: range, 18 to 69%)
and in transplant patients was 105 28.1 mi/mm (an increase of 34%:
range, 10 to 60%), with the greatest increments in those whose
allografts functioned best before conception, regardless of donor source
and sex or the transplant-pregnancy interval. In late pregnancy mean
24-hr Cc. decreased by 19% (range, 6 to 28%) in healthy women and by
34% (range, 12 to 57%) in the transplant patients, but in most this did
not represent graft deterioration nor lead to permanent impairment. At
all time points C1 values were 5 to 10% greater than those for 24-hr Ccr
but slightly less than infusion CCr values. Protein excretion increased
throughout pregnancy and by the third trimester in healthy women
averaged 200 mg in 24 hr and regularly exceeded 500 mg in 24 hr in
transplant patients, which was three times non-pregnant levels and
probably not clinically significant. No definite pattern was evident
regarding the effect of pregnancy on longterm renal prognosis but in
eight of the ten pregnancies GFR had returned to pre-pregnancy values
by 8 to 12 weeks postpartum. It can be concluded that renal allografts
adapt to pregnancy normally and that reduced GFR and proteinuria in
the third trimester are common but usually transient. Further studies
are needed to answer questions on the effects of pregnancy on renal
prognosis.
L'effet de Ia grossesse sur Ia fonction rénale de receveuses d'allogreffes
rénales. Chez les femmes transplantées rénales, le debit de filtration
glomerulaire (GFR) augmente au cours de Ia grossesse, mais la période
a taquelle cette élévation se produit, ses relations avec GFR pré-
gravidique et l'aspect global de cc changement sont inconnus. La
clearance de la créatinine des vingt-quatre heures (24-hr Car) a été
mesurëe prospectivement lors de dix grossesses chez huit receveuses
d'allogreffe depuis avant la conception, pendant la grossesse, 8 a 12
semaines post-partum et 4 a 6 mois plus tard. Les clearances de l'inuline
(C1,,) et de Ia créatinine (Ccr) sous perfusion ont egalement été
déterminées, et l'excrCtion protéique a été évaluée. Les résultats ont
été compares a ceux d'études similaires chez dix femmes normales. A
Ia l0ème semaine de gestation, 24-hr C. était de 124 (SD) 15,9 mi/mm
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chez les femmes normales (une élévation de 38%: extremes, 18 a 69%)
et chez les transplantées de 105 28,1 mI/mm (une élévation de 34%:
extremes 10 a 60%), les plus fortes augmentations survenant chez celles
dont l'allogreffe fonctionnait le mieux avant la conception, quels que
soient l'origine ou le sexe du donneur, ou l'intervalle greffe-grossesse.
En fin de grossesse, 24-hr Cr moyenne a diminué de 19% (extremes, 6
a 28%) chez les femmes normales, et de 34% (extremes, 12 a 57%) chez
les transplantëes, mais chez la plupart cela ne représentait pas une
détérioration du greffon, ni n'a conduit a une alteration permanente. A
tous les temps, les valeurs de C1,, étaient de 5 a 10% pIus élevées que
celles de 24 hr Ccr, mais legèrement moindres que les valeurs de C.
sous perfusion. L'excrétion proteique a augmenté tout au long de Ia
grossesse, et au troisième trimestre Ctait en moyenne de 200 mg par 24
hr chez les femmes normales et dépassait regulièrement 500 mg dans 24
hr chez les transplantées, ce qui correspondait a trois fois les valeurs en
dehors de Ia grossesse et etait probablement sans signification clinique.
Aucun schema précis n'était evident quant a I'effet de Ia grossesse sur
le pronostic renal a long terme, mais apres huit des dix grossesses, GFR
était revenu aux valeurs pré-gravidiques 8 a 12 semaines post-partum.
On peut conclure que les greffons rénaux s'adaptent normalement a La
grossesse et qu'une GFR réduite et une protCinurie au cours du
troisième trimestre sont communes mais habituellement transitoires.
D'autres etudes sont nécessaires pour rCpondre aux questions des effets
de Ia grossesse sur le pronostic renal.
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Giomerular filtration rate (GFR) increases during pregnancy
in renal allograft recipients, exhibiting a change similar to that
observed in normal pregnant women [1J. The increment in
GFR, evident by the end of the first trimester, does not depend
on the sex or age of the donated kidney [21. Such observations,
derived from retrospective analyses, are surprising since it
would be expected that compensatory functional and morpho-
logical hypertrophy in the single transplanted kidney would
have already been maximal prior to conception. Prospective
studies were therefore designed to measure 24-hr creatinine
clearance (24-hr Car) at frequent intervals in ten pregnancies in
eight allograft recipients from before conception, throughout
pregnancy, 8 to 12 weeks postpartum and 4 to 6 monthly
thereafter. Inulin and creatinine clearances (C1,, and Car) were
also determined during infusion studies before, during, and
after pregnancy. In addition, the influence of pregnancy on
protein excretion, an important clinical sign during pregnancy,
was evaluated.
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Table 1. Data of renal allograft patients before, during, and after pregnancy
General information and outcome of pregnancy Blood pressure (BP) and plasma creatinine (Pcr)
Donor
source,
Post-
transplant
Transplant-
pregnancy
Infant
Ges-
Before
pregnancy During pregnancy
Post-delivery follow-up
Dura-
Patient sex, and renal interval tation Weight BP PCr BP Pcr1' tiOn BP PCr
no. age function months weeks kg mm Hg mg/dl mm Hg mg/dl months mm Hg mg/dl
1 LR, M, 32 Immediate 48
120
36
39
3.61
3.52
110/70 0.8
115/75 0.8
115/75 0.6/0.7
120/80 0.7/0.8
63 115/75
30 120/70
0.8
0.8
2 C, M, 23 Immediate 19
41
37
35
2.36
2.23
120/75 0.8
125/80 0.9
125/85 0.7/0.8
135/85 0.7/0.8
13 125/80
20 135/80
0.9
1.0
3 C, M, 51 Immediate 25 38 2.69 130/75 0.8 125/80 0.7/0.9 30 130/80 0.8
4 C, F, 15 Delayed 24 38 2.57 130/80 0.9 135/80 0.8/0.9 30 140/85 1.0
5 C, F, 44 Delayed 96 32 1.60 135/85 1.3 165/105 1.3/2.0 11 150/85 3.4
6 C, M, 18 Delayed 22 37 2.27 120/80 0.9 140/90 0.8/0.9 42 130/80 0.8
7 C, M, 19 Immediate 26 37 3.89 110/70 0.8 130/80 0.6/0.7 32 120/70 0.8
8 C, M, 13 Immediate 30 38 1.94 125/85 0.9 145/95 0.7/1.0 18 130/80 0.8
Abbreviations: LR, living relative; C, cadaver; M, male; F, female; Age, years.
a The values represent the highest BP recorded during pregnancy.
The values are the lowest/highest Pcr values during pregnancy.
Methods
Eight renal transplant recipients have been studied during ten
pregnancies at the facilities of the Medical Research Council
Human Reproduction Group. Each patient was recruited before
pregnancy, having been screened and counselled as a potential
mother according to pre-pregnancy assessment criteria [3]. All
were normotensive and had satisfactory renal function as
evidenced by 24-hr Ccr greater than or equal to 50 mI/mm,
plasma creatinine less than or equal to 1.3 mg/dl (120
moles/liter) and 24-hr protein excretion less than 250 mg.
Clinical details of the patients are presented in Table 1.
Twenty-four hour Ccr and protein excretion were determined
at weekly intervals during several menstrual cycles before
conception, during the conception cycle itself, and throughout
the first trimester of pregnancy. Thereafter, determinations
were made at 2-weekly intervals until 28 weeks of gestation,
then weekly until delivery and after delivery at 8 to 12 weeks
postpartum and 4 to 6 monthly thereafter. Using standard
infusion techniques C1. and Cr were also determined before
conception, during each trimester of pregnancy and 8 to 12
weeks postpartum.
At each time point the patient provided a 24-hr collection of
urine. A fasting blood sample was taken at 8 A.M. on day 2, the
endpoint of the collection and where appropriate the infusion
study was undertaken that morning. Details of the protocols
and laboratory methodology have been detailed elsewhere [4,
5]. True creatinine was determined in both plasma and urine by
a kinetic method using an LKB reaction rate analyzer, thus
avoiding the measurement of non-creatinine chromogens [6].
Inulin in both plasma and urine was determined by a modifica-
tion of the method of Heyrovsky [7]. Urinary protein determi-
nation was by Bio-Rad Protein Assay (Bio-Rad Laboratories,
Richmond, California, USA).
Pregnancy was confirmed by sonar performed at weekly
intervals from the time a menstrual period was 2 weeks over-
due. All patients were taking immunosuppressive drugs: predni-
sone 10 mg/day or less and azathioprine 2 mg/kg body wt/day or
less. In four pregnancies [1(2), 2(2), 7, and 8] azathioprine
Fig. 1. Serial 24-hr creatinine clearance (Car) and mu/in clearance (C10)
during ten pregnancies in eight women with renal transplants (mean
so). Measurements from ten healthy women (mean SD) are shown by
the upper lines and shaded areas.
dosage was halved at 32 weeks of gestation. None of the pa-
tients was taking drugs known to affect creatinine metabolism.
Ten healthy women were recruited before pregnancy and
were studied in an identical manner. All had uncomplicated
pregnancies and gave birth to live babies of average birth weight
for gestation [8].
The significance of differences between pairs of observations
has been assessed by Student's t tests [9]. Values of P < 0.05
are reported as statistically significant. The results are pre-
sented as means and standard deviations (SD).
Results
Changes in renal function throughout pregnancy
The overall patterns of change in 24-hr Cr and C1 before,
throughout, and after pregnancy are shown in Figure 1 and
24-HR CCR CIN
200 Normal
Normal patients
patients
150
patients
1
____________
____________
I I I I}— —-HI I II—'Non- 1st 2nd 3rd 8-12wk Non- 1st 2nd 3rd 8-l2wk
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Table 2. Twenty-four hour creatinine clearance and total protein
excretion during the first trimester of pregnancy in renal allograft and
control patients (mean SD)
Weeks of
pregnancy
Renal allograft recipients Normal subjects
24-hr total 24-hr total
from last protein protein
menstrual 24-hr C. excretion 24-hr Cc. excretion
period mI/mm mg mi/mm mg
(Non-
pregnant) 79 16.2 115 40.1 91 11.1 97 52.1
1 80 14.9 100 60.3 97 13.1 95 61.8
2 83 16.8 98 58.9 99 14.2 94 59.3
3 89 20.1 101 39.2 110 18.9 98 41.8
4 90 19.1 109 48.4 115 17.1 103 49.1
5 97 20.6 100 71.2 117 18.2 108 69.7
6 100 23.9 115 60.8 121 21.7 107 72.6
7 100 28.2 123 63.7 127 16.8 116 62.9
8 102 27.2 120 63.9 130 14.9 110 76.0
9 101 30.9 146 81.0 128 13.2 121 68.2
10 105 28.1 159 78.6 124 15.9 131 61.4
11 101 30.3 154 84.8 125 17.8 138 39.6
12 100 24.8 174 52.7 128 21.1 129 42.8
13 103 29.0 179 63.9 128 20.0 148 67.7
14 110 30.2 163 70.2 130 13.9 141 58.9
15 109 28.2 189 59.9 131 11.3 147 41.8
16 109 30.4 198 77.7 136 11.0 151 39.9
compared to changes in healthy women. There was an increase
in 24-hr Ccr of about 30% in the first trimester (P < 0.01), which
was sustained throughout the second trimester only to decrease
between the second and third trimesters (P < 0.05). C1
increased by 35% in the first trimester (P < 0.001), remained
elevated during the second trimester only to decrease again in
late pregnancy (P < 0.05). At all time points C1 values were 5
to 10% greater than those for 24-hr CCr. The correlations were
significant in all instances: pre-pregnancy, r = 0.83, P < 0.001;
first trimester, r = 0.90, P < 0.001; second trimester, r = 0.91,
P < 0.001; third trimester, r 0.82, P <0.01; and postpartum,
r 0.83, P < 0.01.
During the infusion studies CC. was always greater than C1.
Values for CCr/CIn ratios in the allograft recipients were as
follows: 1.07 0.11, 1.02 0.08, 1.04 0.14, 1.05 0.09,
and 1.06 0.13 for pre-pregnancy, first trimester, second
trimester, third trimester, and postpartum, respectively. These
values were not significantly different from those for the normal
healthy women. Details of time course of early increment and
late decrement in GFR. On the average six nonconceptional
cycles were studied before conception with a range of 2 to 13
cycles. Twenty-four hour CCr was 12% higher during week 4
compared to week 1 of the menstrual cycle (P < 0.05). The
nonpregnant (pre-conception) value was calculated as the aver-
age of the four values obtained during the menstrual cycle
immediately preceding conception.
The changes in 24-hr CCr during early pregnancy are given in
Table 2 and Figure 2 compared to the changes in healthy
women. By week 4 o1 pregnancy values in the transplant
patients were on the average 16% higher than pre-pregnancy
values (P < 0.05) and continued to rise, attaining a peak value
during week 10, which on the average was 34% (range, 10 to
60%) above the non-pregnant value (P < 0.01). The timing and
magnitude of the change across pregnancies was variable, but in
Fig. 2. Changes in 24-hr creatinine clearance measured from before
conception and then during the first trimester of pregnancy in ten
pregnancies in eight women with renal transplants (mean SD).
Measurements from ten healthy women (mean SD) are shown by the
upper line and shaded area.
all of them peak values 10 to 60% above their own non-pregnant
levels were achieved by weeks 9 to 12 of gestation. The
numbers available for analysis made it impossible to identify the
factors determining the extent of the increase in GFR, but there
was no apparent relationship to the age, sex, and donor source
of the kidney transplant or the transplant-pregnancy interval.
Clearly the better the GFR before conception the bigger the
increment in pregnancy. In individual transplant patients the
grafts that had immediate primary function were the ones that
had the highest pre-pregnancy GFR values. The mean incre-
ment was primarily due to increases in pregnancy from five
patients whose grafts had functioned immediately while two
patients with delayed function, who also had the lowest pre-
pregnancy GFR values, demonstrated trivial increases. In the
normal women 24-hr Cr was on the average 25% higher by
gestational week 4 (P <0.05) and attained a peak during week
10 averaging 45% above non-pregnant values (P < 0.001).
Figure 3 demonstrates changes in 24-hr CCr in the transplant
patients compared to healthy subjects for the last 6 weeks
before delivery. There was a downward trend in clearance in
each subject at this time and a significant difference (P < 0.01)
occurred between weeks 6 and 1 before delivery, but linear
regression analysis failed to show a uniform change across
subjects. The mean value for creatinine clearance at 1 week
compared to 6 weeks before delivery was 34% less (range, 12 to
57%). Mean values in the last 3 weeks of pregnancy did not
differ significantly from the non-pregnant mean. In healthy
subjects the mean value for GFR at I week compared to 6
weeks before delivery was 16% less (range, 4 to 25%).
Protein excretion
Protein excretion increased throughout pregnancy (Table 2
and Fig. 4) and by the third trimester it was three times
non-pregnant levels. By 8 to 12 weeks postpartum protein
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Fig. 3. Twenty-ftur hour creatinine clearance (mean SD) during the
6 weeks preceding delivery in ten pregnancies in eight women with renal
transplants. Measurements from ten healthy women (mean SD) are
shown by the shaded area.
excretion had returned to non-pregnant levels. It should be
emphasized that despite these trends in mean values there were
wide variations between individual subjects in the degree and
pattern of change during pregnancy.
Effect of pregnancy on long-term renal function
In eight of the ten pregnancies GFR had returned to pre-
pregnancy levels by 8 to 12 weeks postpartum. However, after
two pregnancies [2(2) and 5] restoration of GFR to pre-
pregnancy values was not evident. This was a second preg-
nancy for patient 2 who had conceived 3.5 years after a cadaver
kidney transplant, following which primary function had been
immediate and a first pregnancy uneventful. Although GFR was
25% less than pre-pregnancy levels, it remained stable for the
rest of the follow-up (20 months). In patient 5, conception
occurred 8 years after cadaver kidney transplantation following
which primary function had been delayed. Not only was GFR
60% less than pre-pregnancy, but the decrease continued and 11
months postpartum endstage renal failure was reached and
transplant nephrectomy had to be performed because of ad-
vanced chronic rejection. Interestingly, another patient (no. 1)
had her second pregnancy 10 years after a living donor trans-
plant; there were no long-term effects on renal function.
Discussion
Changes in GFR
Our results confirm previous reports that GFR increases in
pregnancy in renal transplant recipients and that transient
reduction may occur in the third trimester [11. The results
extend such observations by demonstrating that a 34% mean
increase (range, 10 to 60%) in 24-hr Cr is evident by week 10 of
pregnancy. The greatest increments in GFR occurred in pa-
Trimesters
Fig. 4. Serial 24-hr total protein excretion during ten pregnancies in
eight women with renal transplants (mean SD). Measurements from
ten healthy women (mean SD) are shown by the lower line and
shaded area.
tients whose allografts functioned best before conception
regardless of donor age, source, and sex or the transplant-
pregnancy interval. In most cases a mean decrement of 34%
(range, 12 to 57%) in late pregnancy did not represent deteriora-
tion of the graft or lead to permanent impairment.
Although these changes are beyond the limits of laboratory
error and day-to-day variability [9, 10], there is still controversy
about how closely 24-hr Cc. represents true GFR. Creatinine is
not only filtered at the glomerulus but is also secreted in the
proximal tubule, and thus an alteration in the renal handling of
creatinine could also contribute to the observed changes [10,
11]. The data presented here are similar to our results for
normal pregnancy [5] as well as to those reported in the
literature [11, 13, 14] and demonstrate significant concordance
between 24-hr Ccr and C1, although the latter were on the
average 10% higher. Thus, accepting the relative crudity of
24-hr Ccr it does, nevertheless, give a reasonable estimate of
GFR.
There are, however, additional problems to be considered in
renal transplant patients because the validity of inulin clearance
(C1) as an index of GFR in single kidneys has been questioned.
Rosenbaum et al [15] reported that in kidney recipients and
donors C underestimates GFR when compared to the clear-
ance of markers of GFR such as creatinine (Cc-)and iothalam-
ate (C10). The CcrICin ratio was 1.02 (SD) 0.07 in 11 "normal"
subjects and 1.47 0.67 in 20 transplant recipients. The C10/Cc.
and C10/C1 ratios in "normal" subjects were the same at 1.02
0.13. The C10/C1 ratio was 1.43 0.24 in recipients and 1.22 ±
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0.11 in donors. It was concluded that the erroneous clearances
in donors and recipients were those of inulin and that the
increased renal blood flow and altered glomerular permselec-
tivity characteristics in a single kidney caused impaired inulin
filtration. This hypothesis could be extended to normal preg-
nancy where inulin clearance could also be impaired as a result
of increased renal blood flow. Furthermore, the validity of
inulin clearance data in pregnant patients with a single kidney
would be even more suspect.
Our previous studies, however, do not support this conten-
tion. In one study [16] the CCr/CIn ratio in nine renal donors was
1.03 0.04 which was not significantly different from a value of
1.08 0.9 for simultaneously studied age and sex-matched
controls. In another study [171 the CCr/CIn ratio in 14 renal
transplant recipients was 1 .18 0.22, which was significantly
different (P < 0.05) from 1.03 0.04, the value for renal
donors. Nevertheless, a CCr/CInd ratio of 1.18 0.22 for our
recipients is not as great as that obtained by Rosenbaum et al
[151 for their transplant recipients (1.47 0.67) and is not
significantly different from the value of 1.08 0.09 for our
normal healthy individuals. In the present study, Cr was
always greater than C, under infusion conditions, but the
difference was not significant.
We have shown previously that the increment in GFR is one
of the earliest maternal physiological adaptations detectable in
pregnancy [181. Interestingly, this fundamental change in renal
physiology also occurs in renal allograft recipients despite the
fact that the kidney is ectopic, probably not fully reinnervated,
often from a male donor, potentially compromised by previous
ischemia, immunologically different from the mother and her
fetus and has already undergone renal compensatory
hypertrophy. This study has not investigated the cause of the
increment, but the possible contributory factors have been
discussed elsewhere [19].
Although there are reports of transient reductions in GFR
during the third trimester of pregnancy in allograft recipients
[20, 21], the exact extent of this change has never been
previously determined. Our results suggest a mean decrement
of 34% which is twice that which occurs in normal pregnancy
[22]. In the majority of cases, however, this change was not
accompanied by any other evidence of alteration in kidney
function, nor was it followed by permanent renal impairment.
As our study was conducted under conditions approximating as
closely as possible to the every day pattern of activity during
late pregnancy, this is a change that might be expected in
clinical practice.
Changes in protein excretion
Urinary protein excretion is said to increase during normal
pregnancy, but to our knowledge, there are few data to sub-
stantiate this claim [23]. In this study 24-hr protein excretion
was measured serially in both normal and transplanted patients
and increased excretion was evident in both from early preg-
nancy. After the first trimester, excretion increased even more,
such that in the transplant patients by the second and certainly
the third trimester, it regularly exceeded 500 mg. This was not
usually accompanied by hypertension, any evidence of renal
dysfunction, or marked increments in plasma urate levels. By 8
to 12 weeks after delivery protein excretion had returned to
pre-pregnancy levels which were still greater than in normal
women.
The increased protein excretion in these patients is important
in respect to antenatal care. For instance, a dipstix method such
as Albustix (Ames Company) detects proteinuria at 15 mg/dl or
above and thus in allograft recipients proteinuria will be de-
tected in 70% of the women. In the absence of urinary tract
infection or pre-eclampsia, however, it is usually not clinically
important. Furthermore, when marked proteinuria does occur
its reason is not always clear. For example in subject 5, a
primagravida, third trimester proteinuria was accompanied by
hypertension and edema so that a clinical diagnosis of pre-
eclampsia was made. Open renal biopsy at the time of cesarean
section, however, revealed advanced chronic rejection with no
evidence of glomerular endotheliosis, the classical histological
lesion of pre-eclampsia [241. This example is given because
review of the literature indicates that pre-eclampsia is diag-
nosed on clinical grounds in up to 30% of pregnancies of renal
transplant recipients [25]. Given the normal increment in pro-
teinuria and the other reasons for increased protein excretion in
these patients, these statistics must obviously be questioned.
Moreover, although many of the hypertensive syndromes oc-
curring in pregnant renal transplant recipients are quite severe
there is only one report of a woman where the disease pro-
gressed rapidly to eclampsia [261 and interestingly, she subse-
quently had an uncomplicated successful pregnancy [27].
Pregnancy and long-term renal function
If renal function is normal 2 years post-transplant then
functional survival of the graft at 5 years is about 80% whereas
overall 5-year graft survival is only 56 to 65% in recipients of
living donor kidneys and 30 to 35% in recipients of cadaver
organs [28—31]. We therefore counsel women to wait 2 years
before attempting conception, a view endorsed by the literature
[25]. Further justification for this advice comes from the obser-
vation that neonates born to women who have conceived within
2 years of transplant are generally small for gestational age [32].
Our one case of chronic rejection (no. 5), misdiagnosed as
pre-eclampsia at the time, does not allow generalizations as to
the effect pregnancy has on a renal transplant already manifest-
ing a decline in renal function. It is obvious that awareness of
subclinical rejection is very important when counselling a
potential mother, but unfortunately, it is often not suspected
and is certainly difficult to diagnose. It may be a function of
time; our patient had waited for 8 years before becoming
pregnant, but another (no. 1) had a (second) pregnancy 10 years
after a (live donor) transplant, and renal function did not suffer
as a result, A recent study of cadaver graft recipients (those
who became pregnant and those who did not) suggested that
pregnancy had no effect of graft survival or function [33].
However, this was a small study (five patients having seven
pregnancies compared to ten non-pregnant matched controls)
and like our own does not allow a statement about the effect
pregnancy has on long-term renal prognosis.
A donated kidney undergoes compensatory renal hypertro-
phy at the time of transplantation 1371, and it has been suggested
that the resultant hyperfiltration may cause progressive loss of
renal function due to sclerosis in the glomerulus from the
increased pressures and/or plasma flow [381. Theoretically, the
lifespan of a single kidney could be further jeopardized by the
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additional hyperfiltration of pregnancy. Answers to this ques-
tion and others regarding the long-term effects of pregnancy on
renal transplant function are urgently needed and if multicenter
studies could be set up so then counselling could be based more
on recorded experience than clinical anecdote.
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